ABSTRACT. Opportunistic infections (OIs) are common among human immunodeficiency virus (HIV) patients; however, genetic susceptibility to these infections has not been studied. Recent studies have shown that interleukin-8 (IL-8) A/T genotype carriers are more susceptible to a variety of diseases. In this study, we showed the effects of IL-8 gene polymorphisms on OIs and symptoms such as sexually transmitted diseases (STDs), tuberculosis (TB), diarrhea, shortness of breath, weight loss, and viral load, in HIV and acquired immunodeficiency syndrome patients. Genomic DNA was purified from mouthwash samples collected from patients attending HIV centers in the Vhembe district. The IL-8 (-251) A/T locus was genotyped using allele-specific polymerase chain reaction followed by agarose gel electrophoresis. The results showed a weak association between the IL-8 AA genotype and OIs such as STDs (P = 0.143), diarrhea (P = 0.906), and TB (P = 0.762). Significant associations were found between the IL-8 AT genotype and weight loss (P = 0.019), shortness of breath (P = 0.043), and skin problems (P = 0.003). Low viral load was also found to be significantly associated with IL-8 AA genotype (P = 0.009). The present study suggests that different IL-8 genotypes are associated with resistance to various OIs. However, further studies using larger samples sizes are needed to confirm this hypothesis.
INTRODUCTION
Inflammatory processes are important components of the defense mechanisms of the body. Despite their useful function, inflammatory responses may be greater than required to control the initial impact of infections (Adrie and Pinsky, 2000) . Thus, inflammatory processes may injure a variety of organs and tissues rather than remove pathogens and promote healing (Chiche et al., 2001) . Opportunistic infections (OIs) are one of the most important causes of morbidity and mortality among patients with human immunodeficiency virus (HIV) infections and acquired immunodeficiency syndrome (AIDS). These opportunistic infections occur when the virus continuously damages the immune system such that the immune system can no longer respond to infections. HIV attacks cells of the human immune system, mainly CD4 positive T cells and macrophages, which are key components of the cellular immune system. Cytokines are key protein regulators of host immunity that trigger inflammation in response to infection (Li et al., 2012) . This inflammation is associated with the onset of opportunistic infections in HIV and AIDS patients.
Genetic polymorphisms in cytokines have emerged in recent years as important factors of disease susceptibility and severity. Polymorphic variants of several cytokine genes are thought to play important roles in determining how individuals respond to various environmental conditions, including inflammation, at the cellular level (Mustapha et al., 2012) . Various studies continue to show that host cytokine responses are genetically determined and polymorphic (Kennedy et al., 2012) . In particular, interleukin-8 (IL-8) is considered to be a major polymorphonuclear neutrophil chemoattractant cytokine in bacterial infections (Abul et al., 2001) .
The study of genetic variation associated with disease is an exciting area of medical investigation that explains why some patients quickly succumb to disease when other patients with the same infection remain healthy longer. Biomedical and genetic studies have shown the effects of IL-8 gene polymorphisms in the pathogenesis of chronic inflammatory diseases, such as cancer (Snoussi et al., 2010) , tuberculosis (TB) (Otsuka et al., 2005) , and other infections. Nevertheless, no studies have investigated the effects of IL-8 on OIs in HIV patients. In this study, we aimed to identify potential associations between the IL-8 gene and OIs in HIV patients. The IL-8 gene was genotyped to determine the distribution of IL-8 genotypes (AA, AT, TT) and to identify any association between IL-8 gene polymorphisms and OIs in the Limpopo Province of South Africa.
MATERIAL AND METHODS

Recruitment of subjects and sample collection
The study was approved by the Research Review Board and Ethics Committee of the University of Venda (UNIVEN). The objectives of the study were explained to the patients and written consent was obtained before the administration of the questionnaires and sample collection. Questionnaires were structured to obtain information regarding gender, hospital, treatment taken, and marital status. Mouthwash samples were collected from a total of 201 patients randomly selected from three different hospitals: Donald Frazer, Elim, and Tshilidzini in the Limpopo Province of South Africa. Other samples were collected at UNIVEN. Patients' files were consulted when needed with permission from the hospital review board and the Department of Health, Polokwane. Samples were transported to the molecular genetics laboratory at UNIVEN in a cooler box with ice. Upon arrival to the laboratory, samples were centrifuged at 500 g for 15 min. The resulting pellet was transferred to a 2-mL Eppendorf tube and kept in the freezer at -20°C until further use.
DNA extraction and genotyping
Genomic DNA was extracted from the mouthwash and purified using the Blood Extraction kit (Sigma-Aldrich, Germany) as recommended by the manufacturer. An allele-specific polymerase chain reaction (AS-PCR) was performed to detect the polymorphisms at position -251 of the IL-8 gene promoter region. Beta-globin specific primers were used as an internal control. A PCR mixture was prepared and consisted of 5 μL genomic DNA, 10 μL KAPA ReadyMix Taq polymerase (Kapa Biosystems, Cape Town, South Africa), 0.3 μL each specific and common primer, and nucleasefree water to a final volume of 20 µL. The primers used were 5'-CTAGAAATAAAAAAGCATACAA-3'; (-251A) 5'-CTAGAAATAAAAAAGCATACAT-3' (-251T); and the common primer 5'-AATACGGAGT ATGACGAAA-3'. These primers yielded a PCR product of about 200 bp, as described by Snoussi et al. (2010) . AS-PCR cycling conditions were as follows: predenaturation at 96°C for 10 min, a touchdown procedure of 25 s at 95°C followed by annealing for 45 s at temperatures decreasing from 55°C (four cycles) to 50°C (25 cycles), and elongation at 72°C for 40 s. PCR products were stored at 10°C. The PCR products of the IL-8 gene amplification were loaded onto a 1.5% agarose gel and visualized under the gel documentation system (GBox, Vacutec, Pretoria, South Africa).
Statistical analysis
All results were analyzed using the Statistical Package for Social Science (SPSS, Inc., 2009, Chicago, IL, USA) version 19 Windows program. Pearson's chi-square test and binary analysis were used to determine the potential association between the genotype distribution IL-8 and the different demographic and clinical characteristics of the patients. Comparisons of frequencies for the two groups were tested by the chi-square test. Crude odds ratios as estimates of the relative risk were calculated with a 95% confidence interval. The chi-square statistics were used to find Pearson's chi-square significance and likelihood ratios.
RESULTS
Demographic information of the participants
All participants were grouped according to gender, place where collection took place, and marital status. A majority of the participants were females (61.15%) and age varied between 13 and 73 years. From the entire population, 89 (47.34%) individuals were from Donald Fraser, 49 (26.06%) were from Tshilidzini, 36 (19.15%) were from Elim, and 14 (7.45%) were from UNIVEN (Table 1) . Most infections (86%) were reported to be by sexual intercourse while 2.6% were from mother-to-child transmission. PCR amplification revealed the genotypes. Amplification of the IL-8 A allele produced bands approximately 200 bp long (Figure 1) . Amplification of the IL-8 T allele also produced bands approximately 200 bp in size. Genotypes were determined based on bands that appear as homozygotes or heterozygotes. 1-7) . Genotypes are indicated in the middle of the gels as TT, AA, or TA. 
General distribution of the IL-8 genotypes
Only 188 of the 201 samples were successfully amplified. These 188 samples were analyzed. The homozygous IL-8 AA genotype was predominant in the population (71%), followed by the heterozygous IL-8 AT (25%) genotype and the homozygous IL-8 TT genotype (4%) (Figure 2) . 
IL-8 genotype polymorphisms correlated to opportunistic infections
Several OIs and symptoms were reported by the participants, including sexually-transmitted diseases (STDs), TB, diarrhea, and skin infections. Table 2 shows the distribution of the genotypes in relation to the occurrence of opportunistic infections and symptoms as reported by the patients. Of the 138 patients without STDs, 68% had the AA genotype. Of the 37 patients with STDs, 81% had the AA genotype. However, the difference was not significant (c 2 154 = 2.142, P = 0.143). The TT genotype did not show a significant difference between patients with STDs and patients without STDs (P = 0.784). A significant association was found between the AT genotype and current skin problems (P = 0.003), loss of weight (P = 0.019) and shortness of breath (P = 0.043) ( Table 2) .
IL-8 genotype polymorphisms in relation to immunological characteristics of the participants
The CD4 count was reported for some patients from their files as 162 well as the viral load. Participants with viral loads less than 25 copies (or undetectable) also predominantly had the AA genotype (c 2 164 = 9.367; P = 0.009). A majority of the participants with CD4 counts less than 50 cells/μL carried the AA genotype, but the difference was not significant (P = 0.717). Of the 99 individuals with CD4 counts less than 200 cells/μL, 73 (73.7%) carried the AA genotype, 23 (23.2%) carried the AT genotype, and 3 (3.1%) carried the TT genotype with low significance (P = 0.311) ( Table 3) . GTYP = genotypes; IL-8 = interleukin-8; OIs = opportunistic infections; STD = sexually-transmitted diseases; TB = tuberculosis; Dia. = diarrhea; PSP = past skin problem; CSP = current skin problem; LOW = loss of weight; SOB = shortness of breath; OR = odds ratio. Significance: *P < 0.05. 
DISCUSSION
IL-8 is an important chemokine that acts as a chemoattractant for neutrophils (Kim et al., 2009 ). This chemokine is widely studied because of its associations with various diseases, such as respiratory infections, urinary tract infections, and cancer (Falfán-Valencia et al., 2012) . The pathogenesis of urinary tract inflammation was reported to involve the recruitment of neutrophils into the urinary tracts and chemokine receptor interactions that result in tissue damages (Zaffanello et al., 2010) . Studies in vitro have shown that the IL-8 (-251) A allele tends to be associated with increased IL-8 production and tissue damage in lipopolysaccharide-stimulated whole blood (Hull et al., 2000) . Most studies have thus suggested that the IL-8 (-251) AA genotype is associated with increased risks of various diseases, such as breast cancer (Snoussi et al., 2010) , prostate cancer (McCarron et al., 2002) , enteroaggregative Escherichia coli diarrhea (Jiang et al., 2003) , and TB (Ma et al., 2003) . Most of these diseases can cause serious harm to an HIV patient because they further compromise the immune system and allow HIV to progress rapidly to AIDS, resulting in millions of deaths every year. The present study found that the IL-8 AA genotype is predominant in our study population in Limpopo. However, a study conducted in Texas, USA by Garey et al. (2010) revealed the IL-8 heterozygote to be predominant (27% AA, 53% AT, and 20% TT). In a study by Okada et al. (2009) , the A allele frequency in control subjects was 0.48 in the Uzbekistan Republic. This allele frequency was similar to previous reports for Caucasian populations. They also indicated that the IL-8 -251 AA genotype was associated with higher anti-p53 antibodies. It can therefore be estimated that the majority of the population in our region could be more susceptible to infections and cancer.
Although we did not investigate associations between this genotype and cancer in our population, we found that the AA genotype was associated with skin problems. Skin problems reported by patients in our study were not specific and covered different problems, such as Kaposi' sarcoma, night burn, and dermatitis, some of which are cancers. In a meta-analysis by Xue et al. (2012) , the IL-8 -251 AA genotype was associated with the overall risk of developing gastric cancer and might indicate increased susceptibility to overall gastric cancer in Asian populations. Although similar studies have not been conducted in the African population, our results suggest that the patients could be susceptible to these cancers as well. In the present study, the IL-8 AA genotype was more common among patients with STDs although the difference was not statistically significant. These STDs generally included burning urination, colored and watery discharges, rush, sores, and genital warts. These results are similar to those previously described by van der Kuyl et al. (2004) , who indicated that HIV patients with the AA genotype were more susceptible to AIDS-related Kaposi sarcoma while individuals carrying the TT genotype appeared to be protected. Diarrhea is also common among HIV and AIDS patients and occurs in about 90% of patients. In our study, diarrhea occurred in about 20% of patients and was not significantly associated with any genotype. Although we did not establish the causative agent of diarrhea among these patients, results obtained by Jiang et al (2003) found that individuals with the AA or AT genotype at the -251 position in the promoter region of IL-8 were more likely to develop symptomatic enteroaggregative E. coli infections than those with the TT genotype. It is therefore necessary to further investigate the causes of diarrhea in this population in relation to their genetic background, at least at the -251 position. A highly significant association was found between AA genotype carriers and low viral load (below 25 copies). Since most of our patients were on antiretroviral therapy (ART), it can be argued that drug usage might have improved the viral load of the participants in relation to their CD4 counts. Therefore, further studies are needed to verify the effect of these genotypes in the presence and absence of ARTs. These results indicate that patients carrying the IL-8 AT genotype are less susceptible to most opportunistic infections than IL-8 AA genotype carriers. Hence, this conforms to a similar study in breast cancer (Snoussi et al., 2010) , where carriers of the IL-8 AA genotype were more susceptible to aggressive breast cancer and TB (Ma et al., 2003) . This suggests that the AT genotype might have moderate effects on disease susceptibility, particularly with skin problems and weight loss. Surprisingly, none of the TB patients in our study carried the TT genotype and very few patient IL-8 TT genotype carriers had STDs, diarrhea, shortness of breath, skin problems, or weight loss. This might mean that patients with the IL-8 TT genotype might be resistant to the aforementioned diseases.
The main limitation of this study was the size of the population. The small study size was due to ethical restrictions and the unwillingness of the patients to participate in the study. However, these preliminary results are important to understand the impact of host genetics on the occurrence of OIs and to generate hypotheses for further studies. This study also establishes the association between genetics and biomarkers such as IL-8. To our knowledge, no studies have shown such results. However, a larger sample size is needed to confirm this possible hypothesis. The findings described in the present study indicate that HIV patients in the Vhembe district mostly carried the AA genotype, which has been reported to render the carrier susceptible to several infections in different environments. In addition, our results show that carriers of the IL-8 AA genotype might be less susceptible to OIs such as skin problems, shortness of breath, and STDs than carriers of the AT genotype. Further studies are needed using larger populations in order to confirm the effect of these factors on the occurrence of OIs among patients in the region. These genetic markers may define populations that could benefit from therapeutic interventions such as prophylactic antibiotic therapy or vaccination. Our data showed that the TT genotype was protective against TB.
